Dr Alison Poulton

Senior Lecturer Paediatrics
Paediatrics & Child Health, Nepean Clinical School

Telephone +61 2 4734 3363

Website Poulton on ADHD

Map

Biographical details

I am a paediatrician specialising in treating children with attention deficit hyperactivity disorder (ADHD). I studied medicine at Girton College Cambridge and Guy’s Hospital London, qualifying in 1982. I trained in paediatrics in Stoke-on-Trent and Birmingham UK before migrating to Australia. I completed my advanced training in Melbourne and Sydney and gained the FRACP in 1993. I work at Nepean Hospital, at Penrith Child and Youth Mental Health Service and in private practice in Penrith and have raised a family of four children.

I was awarded my MD from the University of Cambridge in 2011. This was based on research into the collateral effects of stimulant medication on children’s height, weight, physical maturity and body composition.

Research interests

Attention deficit hyperactivity disorder (ADHD)

I have been studying the effects of stimulant medication in children with ADHD since 1996. The initial period of weight loss associated with the appetite suppression that occurs on a stimulant leads to transient slowing of growth and in the longer term, to slower progress through puberty [1] [2]. Stimulant medication improves the symptoms of ADHD, enhancing motivation; it also stabilises the negative mood in oppositional defiant disorder.

Around 40% of children with ADHD also meet diagnostic criteria for oppositional defiant disorder (ODD), which is far higher than would be anticipated by a chance association. I have developed a clinical model, the Mental Effort-Reward Imbalances Model to explain this [3]. The model describes the clinical characteristics of ADHD as the outcome of an interaction between executive functioning deficits and a lack of the subjective experience of reward. In my current research with children with ADHD I am collecting data to test the model and also comparing the clinical effects of dexamphetamine and methylphenidate on the symptoms of ADHD, ODD, mood, appetite and weight.

Obesity

There is substantial overlap between ADHD and obesity; symptoms of ADHD, such as inconsistent motivation and impulsiveness, with lack of meaningful consideration of the consequences of an action, are also common in obesity. The efficacy of the stimulants for treating obesity has long been recognised, but they are not generally considered appropriate due to their abuse potential [4]. However, similar arguments have not prevented their ongoing use in ADHD; moreover opiates are far more addictive but still have an important role in clinical medicine. I am working towards developing an inexpensive intervention that emphasises establishing a healthier lifestyle with the help of a 6 month course of treatment using the stimulant medication dexamphetamine to target the behavioural characteristics that can make weight loss almost unachievable for people with obesity [5].

Population based research and Data linkage

I am interested in the long-term effects of ADHD and stimulant medication at a population level and have been carrying out a data linkage study of the reproductive outcomes of women with previous stimulant treatment for ADHD. I am planning a study of the cardiovascular effects of long-term treatment.

Full text links

[1] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549744/pdf/1687-9856-2012-30.pdf

[2] http://journals.lww.com/intclinpsychopharm/Fulltext/2016/03000/Stimulant_medication_effects_on_growth_and_bone.5.aspx

[3] http://www.intechopen.com/articles/show/title/therapy-for-adhd-directed-towards-addressing-the-dual-imbalances-in-mental-effort-and-reward-as-illu

[4]http://journal.frontiersin.org/article/10.3389/fphar.2016.00105/full

[5] http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321610/

Current projects

Current projects

A randomised controlled trial to investigate the efficacy of dexamphetamine compared to placebo for treating obesity complicated by obstructive sleep apnoea

· This study is currently at the recruitment stage. It would be suitable as a Masters Project for a postgraduate student

Randomised study comparing the effects of the stimulant medications dexamphetamine and methylphenidate for treating attention deficit hyperactivity disorder (ADHD)

· This is being carried out as an MD project with University of Sydney medical students

Retrospective audit of children with attention deficit hyperactivity disorder (ADHD) on a high dose of stimulant medication children and children on standard doses

Planned projects

Population based study of the cardiovascular effects of long-term treatment with stimulant medication in adults

Developing a cost-effective treatment program for obesity using dexamphetamine

Qualitative study of children’s perceptions of stimulant medication for ADHD

Selected grants

2010

  • Nicotine induced foetal growth restriction: is it related to changes in endocrine pancreatic function?; Poulton A; Nepean Medical Research Foundation/Project Grant.

2008

  • Investigation of the effect of a single dose of stimulant medication on appetite and on fasting and; Poulton A; University of Sydney/Internal Scheme.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Poulton, A. (2015). Therapy for ADHD Directed Towards Addressing the Dual Imbalances in Mental Effort and Reward as Illustrated in the Mental Effort-Reward Imbalances Model (MERIM). In Jill M Norvilits (Eds.), ADHD - New Directions in Diagnosis and Treatment, (pp. 303-330). Rijeka: InTech Publishers.
  • Poulton, A. (2012). Growth Monitoring on Psychotropic Medication. In Victor R. Preedy (Eds.), Handbook of Growth and Growth Monitoring in Health and Disease, (pp. 1737-1754). London, England: Springer.

Journals

  • Poulton, A. (2016). Attitudes of Australian neonatologists to resuscitation of extremely preterm infants. Journal of Paediatrics and Child Health, 52(1), 98-99. [More Information]
  • Poulton, A. (2016). Does Metformin Really Increase Height or Is There Some Problem With the Controls? JAMA Pediatrics, 170(6), 620-621. [More Information]
  • Poulton, A., Chen, F., Nanan, R. (2016). Epinephrine administration and pediatric in-hospital cardiac arrest. JAMA, 315(4), 416-417. [More Information]
  • Poulton, A., Bui, Q., Melzer, E., Evans, R. (2016). Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: A prospective cohort study. International Clinical Psychopharmacology, 31(2), 93-99. [More Information]
  • Poulton, A., Hibbert, E., Champion, B., Nanan, R. (2016). Stimulants for the control of hedonic appetite. Frontiers in Pharmacology, 7, 1-8. [More Information]
  • Poulton, A., Zehetner, A. (2015). Cardiovascular Safety of Stimulants in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 25(10), 824-824. [More Information]
  • Poulton, A., Oakeshott, P., Hunt, G. (2015). Mortality after Bladder Augmentation in Children with Spina Bifida. The Journal of Urology, 194(4), 1169-1171. [More Information]
  • Oakeshott, P., Reid, F., Poulton, A., Markus, H., Whitaker, R., Hunt, G. (2015). Neurological level at birth predicts survival to the mid-40s and urological deaths in open spina bifida: A complete prospective cohort study. Developmental Medicine and Child Neurology, 57(7), 634-638. [More Information]
  • Poulton, A., Hibbert, E., Champion, B., Cook, T., Alais, D., Coulshed, D. (2015). Piloting a new approach to the treatment of obesity using dexamphetamine. Frontiers in Endocrinology, 6, 1-6. [More Information]
  • Oakeshott, P., Poulton, A., Hunt, G. (2015). Re: Cross-sectional study of determinants of upper and lower urinary tract outcomes in adults with spinal dysraphism - New recommendations for urodynamic followup guidelines? The Journal of Urology, 194(6), 1827-1828. [More Information]
  • Tripp, N., Hainey, K., Liu, A., Poulton, A., Peek, M., Kim, J., Nanan, R. (2014). An emerging model of maternity care: Smartphone, midwife, doctor? Women and Birth, 27(1), 64-67. [More Information]
  • Poulton, A., Nanan, R. (2014). Drugs for the treatment of obesity. JAMA, 311(17), 1807-1807. [More Information]
  • Poulton, A. (2014). Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence. Evidence-Based Mental Health, 17(1), 16-16. [More Information]
  • Poulton, A., Nanan, R. (2014). The attention deficit hyperactivity disorder phenotype as a summation of deficits in executive functioning and reward sensitivity: does this explain its relationship with oppositional defiant disorder? Australasian Psychiatry, 22(2), 174-178. [More Information]
  • Poulton, A., Sudarsanam, A. (2014). The New INCLEN Diagnostic Tool - A Comment. Indian Pediatrics, 51(6), 448-449.
  • Poulton, A., Rai, D., Venter, K. (2014). Treatments for pediatric status epilepticus. JAMA, 312(9), 962. [More Information]
  • Poulton, A., Melzer, E., Tait, P., Garnett, S., Cowell, C., Baur, L., Clarke, S. (2013). Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder. Medical Journal of Australia, 198(1), 29-32. [More Information]
  • Poulton, A., Liu, A., Nanan, R. (2012). Budesonide in preschool-age children with recurrent wheezing. The New England Journal of Medicine, 366(6), 570-570. [More Information]
  • Nanan, R., Poulton, A., Champion, B. (2012). Clinical pathways: a departure from the art of medicine. Medical Journal of Australia, 196(2), 96-96. [More Information]
  • Suresh, A., Liu, A., Poulton, A., Quinton, A., Amer, Z., Mongelli, M., Martin, A., Benzie, R., Peek, M., Nanan, R. (2012). Comparison of maternal abdominal subcutaneous fat thickness and body mass index as markers for pregnancy outcomes: A stratified cohort study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(5), 420-426. [More Information]
  • Oakeshott, P., Hunt, G., Poulton, A., Reid, F. (2012). Open spina bifida: birth findings predict long-term outcome. Archives of Disease in Childhood, 97(5), 474-476. [More Information]
  • Poulton, A., Briody, J., McCorquodale, T., Melzer, E., Herrmann, M., Baur, L., Duque, G. (2012). Weight loss on stimulant medication: how does it affect body composition and bone metabolism? -- A prospective longitudinal study. International Journal of Pediatric Endocrinology, 30(1), 1-9. [More Information]
  • Poulton, A., Babajanyan, A., Nanan, R. (2011). Restricted elimination diet for ADHD. The Lancet, 377(9777), 1567-1568. [More Information]
  • Eysbouts, Y., Poulton, A., Salmelainen, P. (2011). Stimulant medication in pre-school children in New South Wales. Journal of Paediatrics and Child Health, 47(12), 870-874. [More Information]
  • Delsing, C., van den Wittenboer, E., Liu, A., Peek, M., Quinton, A., Mongelli, M., Poulton, A., Nanan, R. (2011). The relationship between maternal opiate use, amphetamine use and smoking on fetal growth. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51(5), 446-451. [More Information]
  • Poulton, A. (2010). Oral megadose methylphenidate ingestion for suicide attempt. Pediatrics International, 52(5), 852. [More Information]
  • Maheshwari, R., Nair, A., Poulton, A., Nanan, R. (2010). Smoking and brain development in preterm infants. The Journal of Pediatrics, 157(2), 346-347. [More Information]
  • Poulton, A. (2010). Time to redefine the diagnosis of oppositional defiant disorder. Journal of Paediatrics and Child Health, 47, 332-4. [More Information]
  • Poulton, A., Nanan, R. (2009). Age-related changes in motor subtle signs among girls and boys with ADHD. Neurology, 73(15), 1248-1249. [More Information]
  • Oakeshott, P., Hunt, G., Poulton, A., Reid, F. (2009). Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Cerebrospinal Fluid Research, 6(Suppl 2), S4-S4. [More Information]
  • Oakeshott, P., Hunt, G., Poulton, A., Reid, F. (2009). Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Developmental Medicine and Child Neurology, 52(8), 749-753. [More Information]
  • Poulton, A., Nanan, R. (2009). Stimulant medications and growth. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 574-576. [More Information]
  • Poulton, A., Nanan, R. (2008). Effects of Prolonged and Exclusive Breastfeeding on Childhood Behavior and Maternal Adjustment: Evidence From a Large Randomized Trial. Pediatrics, 122(2), 474. [More Information]
  • Poulton, A., Nanan, R. (2008). In the long run, skills are as good as pills for attention deficit hyperactivity disorder. Medical Journal of Australia, 189(5), 295-296. [More Information]
  • Poulton, A., Nanan, R. (2008). Measurement of Growth in Stimulant-Naive Children With Attention-Deficit/Hyperactivity Disorder by Using Cross-sectional and Longitudinal Approaches. Pediatrics, 122(1), 221. [More Information]
  • Nanan, R., Liu, A., Poulton, A. (2008). Nasal CPAP for Very Preterm Infants. New England Journal of Medicine, 358(23), 2520-2521. [More Information]
  • Poulton, A., Kwok, S., Nanan, R. (2008). Overweight in Children and Adolescents in Relation to Attention-Deficit/Hyperactivity Disorder. Pediatrics, 122(4), 910. [More Information]
  • Poulton, A., Nanan, R. (2008). Prior treatment with stimulant medication: A much neglected confounder of studies of growth in children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 18(4), 385-387. [More Information]
  • Nanan, R., Singh, G., Poulton, A. (2008). Reductions in Incidence of Invasive Group B Streptococcal Disease in the United States. JAMA: The Journal of the American Medical Association, 300(14), 1649-1650. [More Information]
  • Nanan, R., Poulton, A. (2008). Routine Measurement of Head Circumference as a Tool for Detecting Intracranial Expansion in Infants. Pediatrics, 121(6), 1298. [More Information]
  • Poulton, A. (2008). To the editor: efficacy of oral iron for the treatment of attention deficit hyperactivity disorder in children with low ferritin levels. Pediatric Neurology, 39(1), 74-74. [More Information]
  • Poulton, A., Melzer, E. (2007). Changes in body composition on stimulant medication in 13 children (12 boys) with attention deficit hyperactivity disorder. Archives of Disease in Childhood, 92(Supplement 1, G/TUES/END5), A14-A14.
  • Poulton, A. (2007). Effect of long-term treatment with stimulant medication on growth? Journal of the American Academy of Child and Adolescent Psychiatry, 46(3), 305 (Letters to the Editor)-305. [More Information]
  • Poulton, A. (2007). Mistakes and misconduct in the research literature: retractions just the tip of the iceberg. Medical Journal of Australia, 186(6), 323-324. [More Information]
  • Poulton, A. (2006). Attention-deficit/hyperactivity disorder, stimulants, statistics, and methodology. Journal of Child and Adolescent Psychopharmacology, 16(4), 507-508. [More Information]
  • Poulton, A. (2006). Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder. Current Opinion in Pediatrics, 18(4), 427-434. [More Information]
  • Poulton, A. (2006). Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder. Expert Review of Neurotherapeutics, 6(4), 551-561. [More Information]
  • Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: a review. Archives of Disease in Childhood, 90(8), 801-806. [More Information]
  • Poulton, A., Halasz, G., Vance, A. (2003). Attention-deficit hyperactivity disorder: Divergent perspectives (multiple letters). Medical Journal of Australia, 178(5), 247-248.
  • Poulton, A., Cowell, C. (2003). Slowing of growth in height and weight on stimulants: A characteristic pattern. Journal of Paediatrics and Child Health, 39(3), 180-185.

2016

  • Poulton, A. (2016). Attitudes of Australian neonatologists to resuscitation of extremely preterm infants. Journal of Paediatrics and Child Health, 52(1), 98-99. [More Information]
  • Poulton, A. (2016). Does Metformin Really Increase Height or Is There Some Problem With the Controls? JAMA Pediatrics, 170(6), 620-621. [More Information]
  • Poulton, A., Chen, F., Nanan, R. (2016). Epinephrine administration and pediatric in-hospital cardiac arrest. JAMA, 315(4), 416-417. [More Information]
  • Poulton, A., Bui, Q., Melzer, E., Evans, R. (2016). Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: A prospective cohort study. International Clinical Psychopharmacology, 31(2), 93-99. [More Information]
  • Poulton, A., Hibbert, E., Champion, B., Nanan, R. (2016). Stimulants for the control of hedonic appetite. Frontiers in Pharmacology, 7, 1-8. [More Information]

2015

  • Poulton, A., Zehetner, A. (2015). Cardiovascular Safety of Stimulants in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 25(10), 824-824. [More Information]
  • Poulton, A., Oakeshott, P., Hunt, G. (2015). Mortality after Bladder Augmentation in Children with Spina Bifida. The Journal of Urology, 194(4), 1169-1171. [More Information]
  • Oakeshott, P., Reid, F., Poulton, A., Markus, H., Whitaker, R., Hunt, G. (2015). Neurological level at birth predicts survival to the mid-40s and urological deaths in open spina bifida: A complete prospective cohort study. Developmental Medicine and Child Neurology, 57(7), 634-638. [More Information]
  • Poulton, A., Hibbert, E., Champion, B., Cook, T., Alais, D., Coulshed, D. (2015). Piloting a new approach to the treatment of obesity using dexamphetamine. Frontiers in Endocrinology, 6, 1-6. [More Information]
  • Oakeshott, P., Poulton, A., Hunt, G. (2015). Re: Cross-sectional study of determinants of upper and lower urinary tract outcomes in adults with spinal dysraphism - New recommendations for urodynamic followup guidelines? The Journal of Urology, 194(6), 1827-1828. [More Information]
  • Poulton, A. (2015). Therapy for ADHD Directed Towards Addressing the Dual Imbalances in Mental Effort and Reward as Illustrated in the Mental Effort-Reward Imbalances Model (MERIM). In Jill M Norvilits (Eds.), ADHD - New Directions in Diagnosis and Treatment, (pp. 303-330). Rijeka: InTech Publishers.

2014

  • Tripp, N., Hainey, K., Liu, A., Poulton, A., Peek, M., Kim, J., Nanan, R. (2014). An emerging model of maternity care: Smartphone, midwife, doctor? Women and Birth, 27(1), 64-67. [More Information]
  • Poulton, A., Nanan, R. (2014). Drugs for the treatment of obesity. JAMA, 311(17), 1807-1807. [More Information]
  • Poulton, A. (2014). Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence. Evidence-Based Mental Health, 17(1), 16-16. [More Information]
  • Poulton, A., Nanan, R. (2014). The attention deficit hyperactivity disorder phenotype as a summation of deficits in executive functioning and reward sensitivity: does this explain its relationship with oppositional defiant disorder? Australasian Psychiatry, 22(2), 174-178. [More Information]
  • Poulton, A., Sudarsanam, A. (2014). The New INCLEN Diagnostic Tool - A Comment. Indian Pediatrics, 51(6), 448-449.
  • Poulton, A., Rai, D., Venter, K. (2014). Treatments for pediatric status epilepticus. JAMA, 312(9), 962. [More Information]

2013

  • Poulton, A., Melzer, E., Tait, P., Garnett, S., Cowell, C., Baur, L., Clarke, S. (2013). Growth and pubertal development of adolescent boys on stimulant medication for attention deficit hyperactivity disorder. Medical Journal of Australia, 198(1), 29-32. [More Information]

2012

  • Poulton, A., Liu, A., Nanan, R. (2012). Budesonide in preschool-age children with recurrent wheezing. The New England Journal of Medicine, 366(6), 570-570. [More Information]
  • Nanan, R., Poulton, A., Champion, B. (2012). Clinical pathways: a departure from the art of medicine. Medical Journal of Australia, 196(2), 96-96. [More Information]
  • Suresh, A., Liu, A., Poulton, A., Quinton, A., Amer, Z., Mongelli, M., Martin, A., Benzie, R., Peek, M., Nanan, R. (2012). Comparison of maternal abdominal subcutaneous fat thickness and body mass index as markers for pregnancy outcomes: A stratified cohort study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 52(5), 420-426. [More Information]
  • Poulton, A. (2012). Growth Monitoring on Psychotropic Medication. In Victor R. Preedy (Eds.), Handbook of Growth and Growth Monitoring in Health and Disease, (pp. 1737-1754). London, England: Springer.
  • Oakeshott, P., Hunt, G., Poulton, A., Reid, F. (2012). Open spina bifida: birth findings predict long-term outcome. Archives of Disease in Childhood, 97(5), 474-476. [More Information]
  • Poulton, A., Briody, J., McCorquodale, T., Melzer, E., Herrmann, M., Baur, L., Duque, G. (2012). Weight loss on stimulant medication: how does it affect body composition and bone metabolism? -- A prospective longitudinal study. International Journal of Pediatric Endocrinology, 30(1), 1-9. [More Information]

2011

  • Poulton, A., Babajanyan, A., Nanan, R. (2011). Restricted elimination diet for ADHD. The Lancet, 377(9777), 1567-1568. [More Information]
  • Eysbouts, Y., Poulton, A., Salmelainen, P. (2011). Stimulant medication in pre-school children in New South Wales. Journal of Paediatrics and Child Health, 47(12), 870-874. [More Information]
  • Delsing, C., van den Wittenboer, E., Liu, A., Peek, M., Quinton, A., Mongelli, M., Poulton, A., Nanan, R. (2011). The relationship between maternal opiate use, amphetamine use and smoking on fetal growth. Australian and New Zealand Journal of Obstetrics and Gynaecology, 51(5), 446-451. [More Information]

2010

  • Poulton, A. (2010). Oral megadose methylphenidate ingestion for suicide attempt. Pediatrics International, 52(5), 852. [More Information]
  • Maheshwari, R., Nair, A., Poulton, A., Nanan, R. (2010). Smoking and brain development in preterm infants. The Journal of Pediatrics, 157(2), 346-347. [More Information]
  • Poulton, A. (2010). Time to redefine the diagnosis of oppositional defiant disorder. Journal of Paediatrics and Child Health, 47, 332-4. [More Information]

2009

  • Poulton, A., Nanan, R. (2009). Age-related changes in motor subtle signs among girls and boys with ADHD. Neurology, 73(15), 1248-1249. [More Information]
  • Oakeshott, P., Hunt, G., Poulton, A., Reid, F. (2009). Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Cerebrospinal Fluid Research, 6(Suppl 2), S4-S4. [More Information]
  • Oakeshott, P., Hunt, G., Poulton, A., Reid, F. (2009). Expectation of life and unexpected death in open spina bifida: a 40-year complete, non-selective, longitudinal cohort study. Developmental Medicine and Child Neurology, 52(8), 749-753. [More Information]
  • Poulton, A., Nanan, R. (2009). Stimulant medications and growth. Journal of the American Academy of Child and Adolescent Psychiatry, 48(5), 574-576. [More Information]

2008

  • Poulton, A., Nanan, R. (2008). Effects of Prolonged and Exclusive Breastfeeding on Childhood Behavior and Maternal Adjustment: Evidence From a Large Randomized Trial. Pediatrics, 122(2), 474. [More Information]
  • Poulton, A., Nanan, R. (2008). In the long run, skills are as good as pills for attention deficit hyperactivity disorder. Medical Journal of Australia, 189(5), 295-296. [More Information]
  • Poulton, A., Nanan, R. (2008). Measurement of Growth in Stimulant-Naive Children With Attention-Deficit/Hyperactivity Disorder by Using Cross-sectional and Longitudinal Approaches. Pediatrics, 122(1), 221. [More Information]
  • Nanan, R., Liu, A., Poulton, A. (2008). Nasal CPAP for Very Preterm Infants. New England Journal of Medicine, 358(23), 2520-2521. [More Information]
  • Poulton, A., Kwok, S., Nanan, R. (2008). Overweight in Children and Adolescents in Relation to Attention-Deficit/Hyperactivity Disorder. Pediatrics, 122(4), 910. [More Information]
  • Poulton, A., Nanan, R. (2008). Prior treatment with stimulant medication: A much neglected confounder of studies of growth in children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology, 18(4), 385-387. [More Information]
  • Nanan, R., Singh, G., Poulton, A. (2008). Reductions in Incidence of Invasive Group B Streptococcal Disease in the United States. JAMA: The Journal of the American Medical Association, 300(14), 1649-1650. [More Information]
  • Nanan, R., Poulton, A. (2008). Routine Measurement of Head Circumference as a Tool for Detecting Intracranial Expansion in Infants. Pediatrics, 121(6), 1298. [More Information]
  • Poulton, A. (2008). To the editor: efficacy of oral iron for the treatment of attention deficit hyperactivity disorder in children with low ferritin levels. Pediatric Neurology, 39(1), 74-74. [More Information]

2007

  • Poulton, A., Melzer, E. (2007). Changes in body composition on stimulant medication in 13 children (12 boys) with attention deficit hyperactivity disorder. Archives of Disease in Childhood, 92(Supplement 1, G/TUES/END5), A14-A14.
  • Poulton, A. (2007). Effect of long-term treatment with stimulant medication on growth? Journal of the American Academy of Child and Adolescent Psychiatry, 46(3), 305 (Letters to the Editor)-305. [More Information]
  • Poulton, A. (2007). Mistakes and misconduct in the research literature: retractions just the tip of the iceberg. Medical Journal of Australia, 186(6), 323-324. [More Information]

2006

  • Poulton, A. (2006). Attention-deficit/hyperactivity disorder, stimulants, statistics, and methodology. Journal of Child and Adolescent Psychopharmacology, 16(4), 507-508. [More Information]
  • Poulton, A. (2006). Growth and sexual maturation in children and adolescents with attention deficit hyperactivity disorder. Current Opinion in Pediatrics, 18(4), 427-434. [More Information]
  • Poulton, A. (2006). Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder. Expert Review of Neurotherapeutics, 6(4), 551-561. [More Information]

2005

  • Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: a review. Archives of Disease in Childhood, 90(8), 801-806. [More Information]

2003

  • Poulton, A., Halasz, G., Vance, A. (2003). Attention-deficit hyperactivity disorder: Divergent perspectives (multiple letters). Medical Journal of Australia, 178(5), 247-248.
  • Poulton, A., Cowell, C. (2003). Slowing of growth in height and weight on stimulants: A characteristic pattern. Journal of Paediatrics and Child Health, 39(3), 180-185.

To update your profile click here. For support on your academic profile contact .